Skip to main content
. 2022 Mar 31;306(5):1665–1672. doi: 10.1007/s00404-022-06527-y

Table 2.

Statistical results

n Mean Std. deviation Min Max
RECIST analysis
 Partial response 11 (64.7%)
 Stable disease 5 (29.4%)
 Progressive disease 1 (5.9%)
 Complete response (CR) 0 (0%)
 No target lesion 2
CA125 (IU/l) levels
 Pre-NACT 23 2,725.49 7,292.59 171.1 35,757.0
 Post-NACT 22 105.27 146.05 9.9 548.0
 Reduction (%) 85.66% 28.99% − 40.83%* 98.81%
PCI
 Pre-NACT 23 29.91 4,49 25 39
 Post-NACT 23 12.65 10.17 0 29
 Reduction 17.26 10.31 2 39

*Negative reduction increase of CA125 level